SRINIVAS AKKARAJU Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SRINIVAS AKKARAJU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SRINIVAS AKKARAJU. SRINIVAS AKKARAJU is Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in aTYR PHARMA INC ($LIFE) and Director in ADURO BIOTECH, INC. ($ADRO) and Director in ZS Pharma, Inc. ($ZSPH) and Director in Principia Biopharma Inc. ($PRNB) and Director in Versartis, Inc. ($VSAR) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Jiya Acquisition Corp. ($JYAC).
SRINIVAS AKKARAJU in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SRINIVAS AKKARAJU: Director
Holdings: 41,503 shares
Current Value: $2,522,967
Latest Transaction: May 19 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SRINIVAS AKKARAJU in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, LIFE, ADRO, ICPT, JYAC, PRNB, SGEN, SYRS, ZSPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 160.33 | 3,171 | 508,406 | 3,171 | |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,335 | 0 | 41,503 | 40.2 K to 41.5 K (+3.32 %) |
| May 07 2020 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 20.06 | 8,500 | 170,510 | 9,000 | |
| May 07 2020 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Sell | S | 167.26 | 8,500 | 1,421,710 | 40,168 | 48.7 K to 40.2 K (-17.47 %) |
| May 07 2020 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Buy | M | 20.06 | 8,500 | 170,510 | 48,668 | 40.2 K to 48.7 K (+21.16 %) |
| Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 19.02 | 4,942 | 93,997 | 0 | |
| Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 19.02 | 12,558 | 238,853 | 4,942 | |
| Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Sell | S | 120.46 | 4,942 | 595,313 | 40,168 | 45.1 K to 40.2 K (-10.96 %) |
| Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Buy | M | 19.02 | 4,942 | 93,997 | 45,110 | 40.2 K to 45.1 K (+12.30 %) |
| Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Sell | S | 119.51 | 12,558 | 1,500,807 | 40,168 | 52.7 K to 40.2 K (-23.82 %) |
| Nov 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Buy | M | 19.02 | 12,558 | 238,853 | 52,726 | 40.2 K to 52.7 K (+31.26 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 2,963 | 0 | 40,168 | 37.2 K to 40.2 K (+7.96 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 2,963 | 0 | 40,168 | 37.2 K to 40.2 K (+7.96 %) |
| Nov 01 2018 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 8.38 | 5,000 | 41,900 | 0 | |
| Nov 01 2018 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Buy | M | 8.38 | 5,000 | 41,900 | 37,205 | 32.2 K to 37.2 K (+15.53 %) |
| May 22 2018 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
| May 22 2018 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 3,700 | 0 | 32,205 | 28.5 K to 32.2 K (+12.98 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 3,700 | 0 | 28,505 | 24.8 K to 28.5 K (+14.92 %) |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 38.82 | 9,260 | 359,473 | 9,260 | |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 3,700 | 0 | 24,805 | 21.1 K to 24.8 K (+17.53 %) |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 39.94 | 9,260 | 369,844 | 9,260 | |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 3,700 | 0 | 21,105 | 17.4 K to 21.1 K (+21.26 %) |
Page: 1